Search tips
Search criteria 


Logo of jexpmedHomeEditorsContactInstructions for Authors
J Exp Med. 1990 July 1; 172(1): 231–237.
PMCID: PMC2188164

Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor


Macrophages and cultured human monocytes can mediate efficient antibody- dependent cytotoxicity (ADCC) against human tumor cells using monoclonal antibodies (mAbs). The mechanism of this killing is usually assumed to involve secreted factors (reactive oxygen intermediates, tumor necrosis factor, or other cytotoxic factors) leading to target cell lysis. In this study, we present evidence that phagocytosis of intact target cells is the principal mechanism of antitumor cytotoxicity in our in vitro model of ADCC by cultured monocytes. Human monocytes cultured in recombinant human macrophage colony-stimulating factor ingested up to 100% of fluorochrome-labeled melanoma and neuroblastoma target cells, in the presence of an appropriate antitumor mAb. Electron microscopy demonstrated phagocytosis of intact tumor cells by cultured monocytes during ADCC. All of the radionuclide in radiolabeled target cells was taken up by monocytes during phagocytosis. By preventing the release of radioisotope tracers, phagocytosis thus prevents the detection of this very efficient form of cytotoxicity by most conventional assays.

Full Text

The Full Text of this article is available as a PDF (849K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Johnson WD, Jr, Mei B, Cohn ZA. The separation, long-term cultivation, and maturation of the human monocyte. J Exp Med. 1977 Dec 1;146(6):1613–1626. [PMC free article] [PubMed]
  • Musson RA. Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity. Am J Pathol. 1983 Jun;111(3):331–340. [PubMed]
  • Munn DH, Cheung NK. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays. J Exp Med. 1989 Aug 1;170(2):511–526. [PMC free article] [PubMed]
  • Cheung NK, Saarinen UM, Neely JE, Landmeier B, Donovan D, Coccia PF. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res. 1985 Jun;45(6):2642–2649. [PubMed]
  • Masui H, Moroyama T, Mendelsohn J. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes. Cancer Res. 1986 Nov;46(11):5592–5598. [PubMed]
  • Woodhouse CS, Morgan AC., Jr Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis. Cancer Res. 1989 May 15;49(10):2766–2772. [PubMed]
  • Mueller BM, Romerdahl CA, Gillies SD, Reisfeld RA. Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody. J Immunol. 1990 Feb 15;144(4):1382–1386. [PubMed]
  • Gillies SD, Lo KM, Wesolowski J. High-level expression of chimeric antibodies using adapted cDNA variable region cassettes. J Immunol Methods. 1989 Dec 20;125(1-2):191–202. [PubMed]
  • Mujoo K, Cheresh DA, Yang HM, Reisfeld RA. Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth. Cancer Res. 1987 Feb 15;47(4):1098–1104. [PubMed]
  • Slezak SE, Horan PK. Cell-mediated cytotoxicity. A highly sensitive and informative flow cytometric assay. J Immunol Methods. 1989 Feb 24;117(2):205–214. [PubMed]
  • Nathan C, Cohn Z. Role of oxygen-dependent mechanisms in antibody-induced lysis of tumor cells by activated macrophages. J Exp Med. 1980 Jul 1;152(1):198–208. [PMC free article] [PubMed]
  • Weiss SJ, Slivka A. Monocyte and granulocyte-mediated tumor cell destruction. A role for the hydrogen peroxide-myeloperoxidase-chloride system. J Clin Invest. 1982 Feb;69(2):255–262. [PMC free article] [PubMed]
  • Nathan C, Brukner L, Kaplan G, Unkeless J, Cohn Z. Role of activated macrophages in antibody-dependent lysis of tumor cells. J Exp Med. 1980 Jul 1;152(1):183–197. [PMC free article] [PubMed]
  • Johnson WJ, Steplewski Z, Matthews TJ, Hamilton TA, Koprowski H, Adams DO. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation. J Immunol. 1986 Jun 15;136(12):4704–4713. [PubMed]
  • Klostergaard J. Role of tumor necrosis factor in monocyte/macrophage tumor cytotoxicity in vitro. Nat Immun Cell Growth Regul. 1987;6(4):161–166. [PubMed]
  • Cannistra SA, Vellenga E, Groshek P, Rambaldi A, Griffin JD. Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood. 1988 Mar;71(3):672–676. [PubMed]
  • Hibbs JB, Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 1987 Jan 23;235(4787):473–476. [PubMed]
  • Klostergaard J, Turpin J, Lopez-Berestein G. Effector mechanisms of human monocyte-mediated tumor cytotoxicity in vitro: parameters of induction of cytotoxins from peripheral blood monocytes isolated by counterflow elutriation. Cancer Res. 1986 Feb;46(2):662–669. [PubMed]
  • Kilbourn RG, Klostergaard J, Lopez-Berestein G. Activated macrophages secrete a soluble factor that inhibits mitochondrial respiration of tumor cells. J Immunol. 1984 Nov;133(5):2577–2581. [PubMed]
  • Johnson WJ, Bolognesi DP, Adams DO. Antibody-dependent cytolysis (ADCC) of tumor cells by activated murine macrophages is a two-step process: quantification of target binding and subsequent target lysis. Cell Immunol. 1984 Jan;83(1):170–180. [PubMed]
  • Helson L, Green S, Carswell E, Old LJ. Effect of tumour necrosis factor on cultured human melanoma cells. Nature. 1975 Dec 25;258(5537):731–732. [PubMed]
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. [PubMed]
  • BENNETT B, OLD LJ, BOYSE EA. THE PHAGOCYTOSIS OF TUMOR CELLS IN VITRO. Transplantation. 1964 Mar;2:183–202. [PubMed]
  • Evans R. Phagocytosis of murine lymphoma cells by macrophages. II. Differences between opsonic and cytotoxic activity of mice immunized with lymphoma cells. Immunology. 1971 Jan;20(1):75–83. [PubMed]
  • Calafat J, Janssen H, Hekman A. Mouse monoclonal antibodies direct phagocytosis of tumor cells by human monocytes. Leuk Res. 1986;10(11):1347–1351. [PubMed]
  • Gardner CR, Wasserman AJ, Laskin DL. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. Cancer Res. 1987 Dec 15;47(24 Pt 1):6686–6691. [PubMed]
  • Drysdale BE, Agarwal S, Shin HS. Macrophage-mediated tumoricidal activity: mechanisms of activation and cytotoxicity. Prog Allergy. 1988;40:111–161. [PubMed]
  • Koren HS, Herberman RB. The current status of human monocyte-mediated cytotoxicity against tumor cells. J Leukoc Biol. 1985 Sep;38(3):441–445. [PubMed]
  • Nakagawara A, Nathan CF, Cohn ZA. Hydrogen peroxide metabolism in human monocytes during differentiation in vitro. J Clin Invest. 1981 Nov;68(5):1243–1252. [PMC free article] [PubMed]
  • Becker S, Warren MK, Haskill S. Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J Immunol. 1987 Dec 1;139(11):3703–3709. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press